Eprosartan (C007B-153345)

Eprosartan is a prototype of the imidazoleacrylic acid angiotensin II receptor antagonist which exhibits antihypertensive properties. It acts on the renin-angiotensin system in two ways to decrease total peripheral resistance. First, it blocks the binding of angiotensin II to AT1 receptors in vascular smooth muscle, causing vascular dilatation. Second, it inhibits sympathetic norepinephrine production, further reducing blood pressure. Specification: 0.95 Molecular Formula: C23H24N2O4S Molecular Weight: 424.52 PubChem CID: 5281037 Isomeric SMILES: CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(/CC3=CC=CS3)/C(=O)O Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/E334970-SCI_e40a560cda427a950a465cb59edca738.pdf

UPC:

51431501

Condition:

New

Weight:

0.96 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

E334970-25mg

CAS:

133040-01-4

Product Size:

25mg

Hazard Statement Codes:

H315:H319

Precautionary Statement Codes:

P264:P280:P302+P352:P305+P351+P338:P362+P364